> Details

Ray, Samrat; Torres-Hernandez, Alejandro; Bleszynski, Michael Sean; Parmentier, Catherine; McGilvray, Ian; Sayed, Blayne Amir; Shwaartz, Chaya; Cattral, Mark; Ghanekar, Anand; Sapisochin, Gonzalo; Tsien, Cynthia; Selzner, Nazia; Lilly, Leslie; Bhat, Mamatha; Jaeckel, Elmar; Selzner, Markus; Reichman, Trevor W.

Medical Assistance in Dying (MAiD) as a Source of Liver Grafts: Honouring the Ultimate Gift

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Medical Assistance in Dying (MAiD) as a Source of Liver Grafts: Honouring the Ultimate Gift
  • Contributor: Ray, Samrat; Torres-Hernandez, Alejandro; Bleszynski, Michael Sean; Parmentier, Catherine; McGilvray, Ian; Sayed, Blayne Amir; Shwaartz, Chaya; Cattral, Mark; Ghanekar, Anand; Sapisochin, Gonzalo; Tsien, Cynthia; Selzner, Nazia; Lilly, Leslie; Bhat, Mamatha; Jaeckel, Elmar; Selzner, Markus; Reichman, Trevor W.
  • Published: Ovid Technologies (Wolters Kluwer Health), 2023
  • Published in: Annals of Surgery, 277 (2023) 5, Seite 713-718
  • Language: English
  • DOI: 10.1097/sla.0000000000005775
  • ISSN: 0003-4932
  • Keywords: Surgery
  • Origination:
  • Footnote:
  • Description: Objective: To report the clinical outcomes of liver transplants from donors after medical assistance in dying (MAiD) versus donors after cardiac death (DCD) and deceased brain death (DBD). Summary Background Data: In North America, the number of patients needing liver transplants exceeds the number of available donors. In 2016, MAiD was legalized in Canada. Methods: All patients undergoing deceased donor liver transplantation at Toronto General Hospital between 2016 and 2021 were included in the study. Recipient perioperative and postoperative variables and donor physiological variables were compared among 3 groups. Results: Eight hundred seven patients underwent deceased donor liver transplantation during the study period, including DBD (n=719; 89%), DCD (n=77; 9.5%), and MAiD (n=11; 1.4%). The overall incidence of biliary complications was 6.9% (n=56), the most common being strictures (n=55;6.8%), highest among the MAiD recipients [5.8% (DBD) vs. 14.2% (DCD) vs. 18.2% (MAiD); P=0.008]. There was no significant difference in 1 year (98.4% vs. 96.4% vs. 100%) and 3-year (89.3% vs. 88.7% vs. 100%) (P=0.56) patient survival among the 3 groups. The 1- and 3- year graft survival rates were comparable (96.2% vs. 95.2% vs. 100% and 92.5% vs. 91% vs. 100%; P=0.37). Conclusion: With expected physiological hemodynamic challenges among MAiD and DCD compared with DBD donors, a higher rate of biliary complications was observed in MAiD donors, with no significant difference noted in short-and long-term graft outcomes among the 3 groups. While ethical challenges persist, good initial results suggest that MAiD donors can be safely used in liver transplantation, with results comparable with other established forms of donation.